We are live on ! Find out more
PC

Polar Capital Portfolio holdings

AUM $13.5B
1-Year Est. Return 55.9%
This Fund
S&P 500
This Quarter Est. Return
+7.37%
1 Year Est. Return
+55.9%
3 Year Est. Return
+127.44%
5 Year Est. Return
+269.08%
10 Year Est. Return
–
AUM
$9.69B
AUM Growth
+$805M
Cap. Flow
+$420M
Cap. Flow %
4.33%
Top 10 Hldgs %
28.55%
Holding
286
New
47
Increased
108
Reduced
76
Closed
36

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$93.3M
2
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$64.9M
3
AMZN icon
Amazon
AMZN
+$58.3M
4
SYK icon
Stryker
SYK
+$56.3M
5
PRAH
PRA Health Sciences, Inc.
PRAH
+$49.9M

Top Sells

Rank Stock Value
1
PEP icon
PepsiCo
PEP
+$77M
2
AMGN icon
Amgen
AMGN
+$72.2M
3
AET
Aetna Inc
AET
+$65.7M
4
CELG
Celgene Corp
CELG
+$54.3M
5
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$52.8M

Sector Composition

Rank Sector Weight
1 Financials 21.51%
2 Healthcare 20.26%
3 Technology 19.08%
4 Communication Services 10.55%
5 Industrials 6.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PGR icon
51
Progressive
PGR
$124B
$50.2M 0.52%
892,000
+27,000
+3% +$1.4M
RHT
52
DELISTED
Red Hat Inc
RHT
$49.7M 0.51%
413,752
+24,511
+6% +$3M
BIDU icon
53
Baidu
BIDU
$35.8B
$49.1M 0.51%
209,514
+180,648
+626% +$44.2M
ABT icon
54
Abbott
ABT
$180B
$49M 0.51%
857,500
-723,417
-46% -$40.1M
FLEX icon
55
Flex
FLEX
$43.4B
$48.5M 0.5%
+3,576,150
New +$48.3M
NVDA icon
56
NVIDIA
NVDA
$5.01T
$48.2M 0.5%
9,967,760
+1,047,440
+12% +$5.2M
EXPE icon
57
Expedia Group
EXPE
$31.2B
$48.2M 0.5%
402,437
+68,374
+20% +$8.87M
CRM icon
58
Salesforce
CRM
$134B
$47.8M 0.49%
467,243
+1,746
+0.4% +$178K
ADBE icon
59
Adobe
ADBE
$89.5B
$47.4M 0.49%
270,414
-4,850
-2% -$834K
SCHW
60
Charles Schwab
SCHW
$177B
$47.1M 0.49%
916,513
+35,958
+4% +$1.69M
XLNX
61
DELISTED
Xilinx Inc
XLNX
$46.1M 0.48%
683,640
+86,175
+14% +$6.11M
TRV icon
62
Travelers Companies
TRV
$80.8B
$45.6M 0.47%
336,000
+58,500
+21% +$7.72M
PBYI icon
63
Puma Biotechnology
PBYI
$406M
$44M 0.45%
445,000
+85,000
+24% +$9.51M
NOW icon
64
ServiceNow
NOW
$102B
$43.8M 0.45%
1,678,565
+19,000
+1% +$472K
XLRN
65
DELISTED
Acceleron Pharma
XLRN
$43.7M 0.45%
1,030,000
-35,000
-3% -$1.31M
NEWR
66
DELISTED
New Relic, Inc.
NEWR
$43.7M 0.45%
756,724
-414,849
-35% -$22.6M
RGA icon
67
Reinsurance Group of America
RGA
$15.7B
$43.4M 0.45%
278,300
+10,300
+4% +$1.56M
EW icon
68
Edwards Lifesciences
EW
$47.6B
$43.4M 0.45%
+1,155,000
New +$42.4M
MDT icon
69
Medtronic
MDT
$107B
$43.2M 0.45%
534,892
-174,349
-25% -$14M
AMG icon
70
Affiliated Managers Group
AMG
$9.46B
$43M 0.44%
209,738
-280
-0.1% -$54.3K
AMAT icon
71
Applied Materials
AMAT
$426B
$42.5M 0.44%
830,882
-576,373
-41% -$31.2M
RNR icon
72
RenaissanceRe
RNR
$13.7B
$42.1M 0.43%
335,500
+65,500
+24% +$8.79M
HUBS icon
73
HubSpot
HUBS
$10.5B
$41.7M 0.43%
471,223
-63,965
-12% -$5.37M
BOX icon
74
Box
BOX
$4.02B
$41.2M 0.43%
1,950,263
+3,873
+0.2% +$81.7K
CNC icon
75
Centene
CNC
$31.3B
$41.1M 0.42%
815,000
+575,000
+240% +$27.9M
1 2
3
4 5

Similar funds

ECM
ETrade Capital Management Arlington, Virginia $5.37B AUM 10.84% 1-Year Est. Return
FAAS
First Allied Advisory Services San Diego, California $2.98B AUM 15.89% 1-Year Est. Return
WAM
Wealthspire Advisors (Maryland) Potomac, Maryland $2.84B AUM 10.91% 1-Year Est. Return
FS
Feinberg Stephen $2.61B AUM 15.12% 1-Year Est. Return
NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
TI
TT International London, United Kingdom $1.94B AUM
VIM
Veritas Investment Management London, United Kingdom $1.65B AUM 25.54% 1-Year Est. Return
PS
Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return

Polar Capital's Q4 2017 Portfolio in Review

As of Q4 2017, Polar Capital held 286 positions worth $9.69B, up 9.1% from $8.89B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Polar Capital deployed $420M of net new capital in Q4 2017, opening 47 new positions and adding to 108 existing holdings. Its largest new stake was Alnylam Pharmaceuticals: 516,232 shares worth $65.6M.

By sector, the portfolio is most concentrated in Financials at 22% of assets, down from 22% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Aetna Inc, an estimated $65.7M trimmed.

  • Polar Capital's largest Q4 2017 buy was Alnylam Pharmaceuticals: 516,232 shares worth $65.6M.
  • Polar Capital added most to Microsoft in Q4 2017, an estimated $93.3M increase.
  • Polar Capital's biggest Q4 2017 reduction was Aetna Inc, cutting an estimated $65.7M.
  • Polar Capital fully exited PepsiCo in Q4 2017, selling an estimated $77M.
  • Polar Capital's ten largest holdings make up 29% of its $9.69B portfolio in Q4 2017.
  • Polar Capital opened 47 new positions and closed 36 in Q4 2017.
  • Polar Capital's portfolio value rose 9.1% quarter-over-quarter to $9.69B.

Based on Polar Capital's 13F filing for Q4 2017, filed 14 Feb 2018.